Skip to main content
. 2020 Jun 5;4(3):229–237. doi: 10.1016/j.mayocpiqo.2020.02.005

Table 2.

Hazard Ratios for All-cause mortality in the Patient Cohortab

Group Patients (No.) Hazard ratios
Unadjusted P value Risk adjustedc P value
CAC score
 0-99 1134 1 (Referent) 1 (Referent)
 100-399 573 1.40 (1.12-1.75) .003 1.21 (0.95-1.55) .12
 ≥400 611 2.07 (1.70-2.52) <.001 1.59 (1.26-2.01) <.001
Physical activity level
 High 551 1 (Referent) 1 (Referent)
 Moderate 1365 1.39 (1.10-1.74) .006 1.26 (0.98-1.63) .08
 Low 402 1.68 (1.28-2.20) <.001 1.60 (1.18-2.17) .003
CAC score/physical activity level
 0-99/high 276 1 (Referent) 1 (Referent)
 0-99/moderate 679 1.19 (0.82-1.73) .36 1.01 (0.67-1.52) .96
 0-99/low 179 1.14 (0.70-1.85) .59 0.97 (0.57-1.64) .90
 100-399/high 136 1 (Referent) 1 (Referent)
 100-399/moderate 329 1.07 (0.69-1.66) .77 1.15 (0.71-1.87) .58
 100-399/low 108 1.37 (0.83-2.29) .22 2.07 (1.16-3.69) .01
 ≥400/high 139 1 (Referent) 1 (Referent)
 ≥400/moderate 357 1.91 (1.28-2.83) .001 1.68 (1.06-2.66) .03
 ≥400/low 115 2.63 (1.69-4.10) <.001 2.35 (1.39-3.97) .001
a

CAC = coronary artery calcium.

b

A formal test for interaction showed that the Wald P value interaction between CAC score and physical activity level was significant (P=.013 unadjusted and P=.009 risk adjusted).

c

Hazard ratios adjusted for age, male sex, hypertension, dyslipidemia, smoking, diabetes, and family history of premature coronary artery disease, lipid-lowering medication use, and blood pressure medication use.